Entera Bio Ltd. announced that in connection with her appointment as Chief Executive Officer, Ms. Toledano will no longer serve as the Company's Chief Financial Officer (principal financial officer) effective on July 15, 2022.  On July 13, 2022, the Board appointed Dana Yaacov-Garbeli, who is the Company's Israel-based Chief Financial Officer and principal accounting officer, to serve as the Company's Chief Financial Officer (principal financial officer) effective on July 15, 2022. Ms. Yaacov-Garbeli, who is 38 years old, has served as the Company's Israel-based Chief Financial Officer since June 2019. Ms. Yaacov-Garbeli has over 15 years of chief finance and accounting experience.

She previously served as Senior Manager at PwC Israel overseeing audits of public and private companies.  She is an expert in financial planning, operations management, external and internal audit for public multinational companies under US GAAP, IFRS and PCAOB standards. Ms. Yaacov-Garbeli is also a partner at A2Z-Finance, a company that provides financial and accounting services.  Ms. Yaacov-Garbeli holds a B. A in accounting and business management and an MBA in financial management from The College of Management and Academic studies. Ms. Yaacov-Garbeli is a Certified Public Accountant in Israel.